Press Releases - 2021-02-23

Date	Title	Company
23-Feb-2021	HemogloBind™ Cited in Comparison Proteomics Study of Covid-19 Patients in Peripheral Blood – The Barometer of the Immune System	Biotech Support Group
23-Feb-2021	Cleanascite™ Employed to Investigate Central Nervous System (CNS) Cell Response	Biotech Support Group
23-Feb-2021	Parse Biosciences Launches Whole Transcriptome Kit to Dramatically Scale Single Cell Sequencing	Parse Biosciences
23-Feb-2021	Sputnik V authorized in 30 countries	Russian Direct Investment Fund
23-Feb-2021	Sputnik V granted emergency use authorization in Ghana	Russian Direct Investment Fund
23-Feb-2021	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference	Pfizer
23-Feb-2021	Diaprost Announces Promising New Study for Patients with Metastatic PCa	Diaprost
23-Feb-2021	Medicines and Healthcare Products Regulatory Agency (MHRA) Authorises Seagen’s TUKYSA® (tucatinib) as Part of Combination Regimen for the Treatment of Adult Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer	Seagen UK Ltd
23-Feb-2021	Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque Psoriasis	Amgen
23-Feb-2021	Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidate	Sanofi
23-Feb-2021	Sanofi to provide manufacturing support to Johnson & Johnson for their COVID-19 vaccine to help address global supply demands	Sanofi
23-Feb-2021	NovalGen enters strategic partnership with HALIX B.V. to manufacture clinical trial materials	NovalGen
23-Feb-2021	Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico	Novavax
23-Feb-2021	Anthony Nolan Cell & Gene Therapy Services and ONK Therapeutics Announce Collaboration	ONK Therapeutics
23-Feb-2021	MaxiVAX and Minaris Regenerative Medicine Enter into a Manufacturing Partnership for MVX-ONCO-2 Cancer Immunotherapy	MaxiVAX and Minaris Regenerative Medicine
23-Feb-2021	Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidate	Sanofi and GSK
23-Feb-2021	SB3000 ApS has been awarded a grant from the Danish Innovation Fund, to further refine its continuous manufacturing enabling technology μLOT® which will revolutionise the production of medicines.	SB3000 ApS
23-Feb-2021	Critical Care Ventilators Remains in Superior Demand in the Medical Ventilators Market	MARKITWIRED
23-Feb-2021	Topmost Makers Concentrate on M and A’s in the Medical Masks Market	MARKITWIRED
23-Feb-2021	Production Collaborations Favored to Undertake Massive Demand Expansion in the Medical Protective Equipment Market	MARKITWIRED